Lucinda Smith is a Partner in the firm’s Corporate team. She also sits on the firm’s National Executive Team, in the role of Partner – Service Delivery. In this role, she manages and oversees the firm’s ability to drive improvement in and modernisation of our service delivery in all parts of our business.

Lucinda is a specialist in the health, aged care, and retirement village industries and brings a commercial, solutions-driven approach to corporate transactions. Her work in the industry focuses on mergers and acquisitions/corporate structuring, regulatory advice, projects (including the development of new hospitals, care facilities, and villages), and operational contracts.

Lucinda’s clients include major players in the corporate, health, aged care and retirement village sectors, research institutes, and health funds.

Lucinda has been recognised by her peers as ‘Lawyer of the Year’ by Best Lawyers in Australia in the areas of Retirement Villages and Senior Living Law (2013, 2017 & 2019) and Non-Profit/Charities Law (2023) in Sydney. In this same publication, she has been recognised by her peers as one of the Best Lawyers in Australia in the areas of Non-Profit/Charities Law (2019 – 2022), Health & Aged Care (2014 – 2022), and Retirement Villages and Senior Living Law (2012 – 2022).

Lucinda has also been recognised by Doyle’s Guide as a market leader (2021) and a preeminent lawyer (2017 – 2020) in New South Wales; and a preeminent lawyer (2017 – 2019) in Australia in the area of Health & Aged Care.

Lucinda Smith’s recent experience includes:

  • Advised Ingenia Communities on its acquisition of 5 rental retirement villages and a tourist park. The purchases incorporated 274 senior village rental units and 236 cabin and camp sites. The units are located throughout New South Wales, Victoria, and Tasmania.
  • Advised Chris O’Brien Lifehouse Project on the A$260 million Lifehouse facility for the provision of integrated cancer services in a new purpose-built facility on the Royal Prince Alfred Hospital campus in Sydney. This partnership is the first of its kind in Australia, and will result in one of the most significant cancer treatment and research facilities in Australia.